Sunday, September 20, 2026

Pfizer Stock Rises As Session Comes To An End On Tuesday, Outperforms Market

ViaNews Editorial Team

December 1, 2020

Pfizer Stock Rises As Session Comes To An End On Tuesday, Outperforms Market

Shares of Pfizer rose 2.62% to $39.31 at 15:12 EST on Tuesday, after two successive sessions in a row of gains. The New York Stock Exchange is jumping 1.27% to $14,183.90, following yesterday's downward trend, on what at the moment seems, an all-around positive trend exchanging session today.

Pfizer's last close was $38.31, 3.03% below its 52-week high of $40.50.

News about Pfizer today

According to today's article on Bloomberg Quint, "Pfizer, BioNTech Seek Clearance to Sell Covid Vaccine in Europe."

Pfizer, biontech seek EU clearance for covid-19 vaccine. According to today's article on Bloomberg Quint, "Pfizer Inc"

Pfizer-biontech seeks EU clearance for coronavirus vaccine. According to today's article on ForexLive, "Pfizer vaccine can be in use in the EU by the year-end if cleared Pfizer-BioNTech just announced that they have submitted an application to the EMA today to seek clearance for coronavirus vaccine use in the EU.."

Pfizer, biontech file for covid-19 vaccine approval in europe. According to today's article on The Wall Street Journal, "Pfizer and partner BioNTech said they are seeking approval from the European Union for their coronavirus vaccine.."

Pfizer's Sales

Pfizer's sales growth is a negative 9.7% for the current quarter and a decline by 9.1% for the next. The company's growth estimates for the current quarter and the next is a negative 12.7% and a negative 12.5%, respectively.

Pfizer's Revenue

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.

Pfizer's Stock Top and Bottom Yearly Value

Pfizer's stock is valued at $39.31 at 15:12 EST, under its 52-week high of $40.50 and way above its 52-week low of $26.45.

Pfizer's Moving Average

Pfizer's value is way above its 50-day moving average of $35.66 and way above its 200-day moving average of $34.81.

Previous days news about Pfizer

According to Bloomberg Quint on Fri Nov 27, "Malaysia Inks Pact With Pfizer to Vaccinate 6.4 Million Citizens."

Stocks making the biggest moves in the premarket: astrazeneca, disney, Pfizer, Amazon & more. According to CNBC on Fri Nov 27, "The stocks making the biggest moves in premarket trading include AstraZeneca, Disney, Pfizer, Amazon, and more.."

According to Bloomberg Quint on Sat Nov 28, "U.K"

According to Bloomberg Quint on Sat Nov 28, "U.K"

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com